IperionX Limited ADR (IPX)

IperionX Limited ADR is a depositary receipt representing common stock of IperionX Limited, a materials company focused on titanium and other critical minerals. Through its U.S. operations, the company develops mineral properties in Tennessee, where it holds a 100% interest in the Titan project, which contains titanium, zircon, and rare earth mineral resources. IperionX also produces angular and spherical titanium metal powders. Its customer markets include automotive and transport, consumer electronics, aerospace and defense, energy, medical, luxury goods, and industrial applications. The company was incorporated in 2017, formerly operated under the name Hyperion Metals Limited, and adopted its current name in February 2022. It is headquartered in Charlotte, North Carolina.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-IPX
$15.97
-23.4% Downside
Overvalued
$45.50
118.2% Upside
Bargain
Weak
0.0%
September 23, 2026
7.2x
774.3 M
708.8 M
0.6%
80.5%
17.3
102.6%
Valuation • Fair Value

IperionX Limited ADR (NASDAQ-IPX) Fair Value by Valuation Model

Review the available estimates for IperionX Limited ADR (NASDAQ-IPX), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$15.97

Estimated downside of 23.4% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$16.48

Discounted cash flow valuation reference.

Comps Fair Value

$15.59

Comparable-company valuation reference.

Analyst Price Target

$45.50

Analysts imply upside of 118.2%.

How to read these valuation models

Use the 5 available valuation references for IperionX Limited ADR (NASDAQ-IPX) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for IperionX Limited ADR (NASDAQ-IPX)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

100 K

Forward revenue estimate.

EBITDA

-52.645 M

Current operating profitability reference.

EBITDA Forecast

-56.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review IperionX Limited ADR (NASDAQ-IPX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for IperionX Limited ADR (NASDAQ-IPX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

2

Weak quality score that deserves closer review.

Altman Z-Score

17.3

Relatively strong balance-sheet zone.

FCF / Net Income

102.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for IperionX Limited ADR (NASDAQ-IPX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for IperionX Limited ADR (NASDAQ-IPX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

September 23, 2026

Days to Earnings

5

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for IperionX Limited ADR (NASDAQ-IPX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

IperionX Limited ADR (NASDAQ-IPX) Stock Forecast & Technical Outlook

Review IperionX Limited ADR (NASDAQ-IPX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for IperionX Limited ADR (NASDAQ-IPX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for IperionX Limited ADR (NASDAQ-IPX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for IperionX Limited ADR (NASDAQ-IPX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for IperionX Limited ADR (NASDAQ-IPX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for IperionX Limited ADR (NASDAQ-IPX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for IperionX Limited ADR (NASDAQ-IPX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, IperionX Limited ADR (NASDAQ-IPX) has a Strong Buy consensus, with 6 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 6
Hold 0
Sell 0
FAQ Fast Investor Answers

IperionX Limited ADR (NASDAQ-IPX) Stock FAQ

Data-supported answers about IperionX Limited ADR (NASDAQ-IPX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$15.97
Estimated downside 23.4%
Valuation Rating
Overvalued
Estimated downside of 23.4%
Analyst Target
$45.50
Implied upside 118.2%
Financial Health
Weak
Current financial-health read

The current fair value estimate for IperionX Limited ADR (NASDAQ-IPX) is $15.97. This implies an estimated downside of 23.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 23.4% versus the current market price.

The available analyst price target for IperionX Limited ADR (NASDAQ-IPX) is $45.50. The analyst target implies estimated upside of 118.2%.

The current financial health read for IperionX Limited ADR (NASDAQ-IPX) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for IperionX Limited ADR (NASDAQ-IPX) is September 23, 2026.

The latest available data indicates no current dividend yield for IperionX Limited ADR (NASDAQ-IPX).

The current market capitalization listed for IperionX Limited ADR is 774.3 M.

The current enterprise value listed for IperionX Limited ADR is 708.8 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for IperionX Limited ADR is NASDAQ-IPX, and the stock is listed on NASDAQ.

IperionX Limited ADR (NASDAQ-IPX) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for IperionX Limited ADR is 0.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for IperionX Limited ADR is 80.5%. Free float helps investors understand how much of the share base is available for public trading.